Phase 4 ADHD trials recruiting now

All ADHD trials, every phase

Other phases for ADHD

Phase 4 ADHD trials

• A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
  NCT06248229 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• AWARE: Management of ADHD in Autism Spectrum Disorder
  NCT05916339 · Phase: Phase 4 · Ages: 4 Years to 17 Years · Sex: All (male and female) · 12 locations
• An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
  NCT06577779 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Atomoxetine and Executive Function in PTSD
  NCT06573970 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
  NCT04421248 · Phase: Phase 4 · Ages: 8 Years to 12 Years · Sex: All (male and female) · 2 locations
• Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
  NCT03781752 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 4 locations
• Effect of GABA on ADHD and Seizures in Children With Epilepsy.
  NCT04144439 · Phase: Phase 4 · Ages: 4 Years to 18 Years · Sex: All (male and female) · 1 location
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
  NCT04781140 · Phase: Phase 4 · Ages: 48 Months to 69 Months · Sex: All (male and female) · 47 locations
• Medication Treatment of ADHD in Pediatric Epilepsy
  NCT07594652 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
  NCT05776056 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
  NCT02951754 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Methylphenidate in KBG Syndrome: N-of-1 Series
  NCT06465641 · Phase: Phase 4 · Ages: 6 Years to 20 Years · Sex: All (male and female) · 1 location
• Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
  NCT04781972 · Phase: Phase 4 · Ages: 6 Years to 40 Years · Sex: All (male and female) · 1 location
• Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
  NCT06871488 · Phase: Phase 4 · Ages: 7 Years to 12 Years · Sex: All (male and female) · 1 location
• R61/33 - VR Study Phase 4
  NCT07169760 · Phase: Phase 4 · Ages: 18 Years to 25 Years · Sex: All (male and female) · 2 locations
• Stimulant Effects on Disruptive Behavior
  NCT03420339 · Phase: Phase 4 · Ages: 48 Months to 12 Years · Sex: All (male and female) · 1 location
• Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
  NCT03781765 · Phase: Phase 4 · Ages: 7 Years to 12 Years · Sex: All (male and female) · 1 location
• The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
  NCT06853665 · Phase: Phase 4 · Ages: 8 Years to 18 Years · Sex: All (male and female) · 1 location
• Treating Young Children With Attention Deficit Hyperactivity Disorder
  NCT07300956 · Phase: Phase 4 · Ages: 3 Years to 5 Years · Sex: All (male and female) · 5 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.